Persistent dry irritative cough
Specialty: Respiratory.
Why it occurs
- Treatment with angiotensin-converting enzyme (ACE) inhibitors (the local accumulation of bradykinins and substance P in the airways directly stimulates nociceptive C fibers, causing persistent non-productive dry cough)
- Cough-variant asthma (cough-variant asthma, where bronchial inflammation manifests only with a dry cough when faced with physical or environmental triggers)
- Gastroesophageal reflux disease (GERD) with microaspiration or stimulation of the esophagobronchial vagal reflex
- Non-asthmatic eosinophilic bronchitis (characterized by eosinophilic inflammation of the airway without obstruction or hyperreactivity demonstrable in spirometry)
- Early bronchogenic carcinoma located in the central airways (irritation of cough receptors due to early tumor growth).
Initial workup
Digital chest x-ray in two projections (first step required); Forced spirometry with bronchodilator test; Cough monitoring and trial of ACEI withdrawal for a minimum of 4 weeks; 24-hour esophageal pH-metry; Eosinophil count in induced sputum.
red flags
Cough that persists for more than 8 weeks despite withdrawal of suspicious drugs and symptomatic treatment, associated hemoptysis, progressive dyspnea, new-onset dysphonia that does not subside, or pathological chest x-ray with infiltrates or nodules.
Standard management
- Enalapril or Lisinopril — discontinue immediately and replace with an angiotensin II receptor antagonist such as Losartan 50 mg orally daily if the cause
- Budesonide — inhaled, 200-400 micrograms every 12 hours if variant asthma or eosinophilic bronchitis is suspected
- Levodropropicin — peripherally acting cough suppressant, 60 mg orally every 8 hours for short-term symptomatic control
- Codeine (15-30 mg orally every 8 hours as a centrally acting alternative).
Educational guidance for study. It is NOT a prescription recommendation. The actual choice depends on the cause, the patient, and current guidelines.
- Area
- Respiratory
- Listed causes
- 5
- Treatment options
- 4